174 related articles for article (PubMed ID: 21203565)
1. Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region.
Zhang Y; Zhu S; Yan D; Liu G; Bai R; Wang D; Chen L; Zhu H; An H; Kew O; Xu W
PLoS One; 2010 Dec; 5(12):e15300. PubMed ID: 21203565
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
Blomqvist S; Bruu AL; Stenvik M; Hovi T
J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
[TBL] [Abstract][Full Text] [Related]
4. Rare natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus isolated from a case of acute flaccid paralysis in Brazil, 2015.
Cassemiro KMSM; Burlandy FM; da Silva EE
J Gen Virol; 2016 Jul; 97(7):1545-1550. PubMed ID: 27082658
[TBL] [Abstract][Full Text] [Related]
5. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
[TBL] [Abstract][Full Text] [Related]
6. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant.
Dedepsidis E; Pliaka V; Kyriakopoulou Z; Brakoulias C; Levidiotou-Stefanou S; Pratti A; Mamuris Z; Markoulatos P
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):343-51. PubMed ID: 18328076
[TBL] [Abstract][Full Text] [Related]
7. Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.
Yan D; Zhang Y; Zhu S; Chen N; Li X; Wang D; Ma X; Zhu H; Tong W; Xu W
Clin Vaccine Immunol; 2014 Jul; 21(7):1012-8. PubMed ID: 24850620
[TBL] [Abstract][Full Text] [Related]
8. Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China.
Tao Z; Wang H; Xu A; Zhang Y; Song L; Zhu S; Li Y; Yan D; Liu G; Yoshida H; Liu Y; Feng L; Chosa T; Xu W
Virus Res; 2010 Jun; 150(1-2):56-60. PubMed ID: 20206214
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
[TBL] [Abstract][Full Text] [Related]
10. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
11. Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.
Liu HM; Zheng DP; Zhang LB; Oberste MS; Kew OM; Pallansch MA
J Virol; 2003 Oct; 77(20):10994-1005. PubMed ID: 14512548
[TBL] [Abstract][Full Text] [Related]
12. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
Georgopoulou A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
[TBL] [Abstract][Full Text] [Related]
13. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.
MartÃn J; Samoilovich E; Dunn G; Lackenby A; Feldman E; Heath A; Svirchevskaya E; Cooper G; Yermalovich M; Minor PD
J Virol; 2002 Nov; 76(21):10921-8. PubMed ID: 12368335
[TBL] [Abstract][Full Text] [Related]
14. Characterization of four vaccine-related polioviruses including two intertypic type 3/type 2 recombinants associated with aseptic encephalitis.
Liu J; Zhang H; Zhao Y; Xia L; Guo C; Yang H; Luo N; He Z; Ma S
Virol J; 2016 Sep; 13(1):162. PubMed ID: 27677968
[TBL] [Abstract][Full Text] [Related]
15. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
Friedrich F; Da-Silva EF; Schatzmayr HG
Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
[TBL] [Abstract][Full Text] [Related]
16. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.
Arita M; Zhu SL; Yoshida H; Yoneyama T; Miyamura T; Shimizu H
J Virol; 2005 Oct; 79(20):12650-7. PubMed ID: 16188967
[TBL] [Abstract][Full Text] [Related]
17. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.
Blomqvist S; Savolainen-Kopra C; Paananen A; El Bassioni L; El Maamoon Nasr EM; Firstova L; Zamiatina N; Kutateladze T; Roivainen M
Virus Res; 2010 Aug; 151(2):246-51. PubMed ID: 20493912
[TBL] [Abstract][Full Text] [Related]
18. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011.
Gumede N; Lentsoane O; Burns CC; Pallansch M; de Gourville E; Yogolelo R; Muyembe-Tamfum JJ; Puren A; Schoub BD; Venter M
Emerg Infect Dis; 2013 Oct; 19(10):1583-9. PubMed ID: 24047933
[TBL] [Abstract][Full Text] [Related]
19. Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China.
Liu HM; Zheng DP; Zhang LB; Oberste MS; Pallansch MA; Kew OM
J Virol; 2000 Dec; 74(23):11153-61. PubMed ID: 11070012
[TBL] [Abstract][Full Text] [Related]
20. [Genetic Characteristics of Type 2 Vaccine-derived Poliovirus in Shanxi Province (China) in 2014].
Yan D; Li X; Zhang Y; Yang J; Zhu S; Wang D; Zhang C; Zhu H; Xu W
Bing Du Xue Bao; 2015 Mar; 31(2):157-63. PubMed ID: 26164941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
